Effects of Estrogen With and Without Progestin and Obesity on Symptomatic Gastroesophageal Reflux

Gastroenterology

Volumn 135, Issue 1, 2008, Pages 72-81

  Zheng, Zongli ^a   Margolis, Karen L ^b   Liu, Simin ^c   Tinker, Lesley F ^d   Ye, Weimin ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b HEALTHPARTNERS RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTACID AGENT; CONJUGATED ESTROGEN; CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; HISTAMINE H2 RECEPTOR ANTAGONIST; PROTON PUMP INHIBITOR;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GASTROESOPHAGEAL REFLUX; HORMONAL THERAPY; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; WAIST CIRCUMFERENCE; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 46049113281     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2008.03.039     Document Type: Article

References (32)

1. Locke III G.R., Talley N.J., Fett S.L., et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 112 (1997) 1448-1456
2. El-Serag H.B., Petersen N.J., Carter J., et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology 126 (2004) 1692-1699
3. Nilsson M., Johnsen R., Ye W., et al. Prevalence of gastro-oesophageal reflux symptoms and the influence of age and sex. Scand J Gastroenterol 39 (2004) 1040-1045
4. Revicki D.A., Wood M., Maton P.N., et al. The impact of gastroesophageal reflux disease on health-related quality of life. Am J Med 104 (1998) 252-258
5. Lagergren J., Bergstrom R., Lindgren A., et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340 (1999) 825-831
6. Devesa S.S., Blot W.J., and Fraumeni Jr. J.F. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83 (1998) 2049-2053
7. Sandler R.S., Everhart J.E., Donowitz M., et al. The burden of selected digestive diseases in the United States. Gastroenterology 122 (2002) 1500-1511
8. Kleinman L., McIntosh E., Ryan M., et al. Willingness to pay for complete symptom relief of gastroesophageal reflux disease. Arch Intern Med 162 (2002) 1361-1366
9. Van Thiel D.H., Gavaler J.S., Joshi S.N., et al. Heartburn of pregnancy. Gastroenterology 72 (1977) 666-668
10. Schulze K., and Christensen J. Lower sphincter of the opossum esophagus in pseudopregnancy. Gastroenterology 73 (1977) 1082-1085
11. Fisher R.S., Roberts G.S., Grabowski C.J., et al. Inhibition of lower esophageal sphincter circular muscle by female sex hormones. Am J Physiol 234 (1978) E243-E247
12. Marrero J.M., Goggin P.M., de Caestecker J.S., et al. Determinants of pregnancy heartburn. Br J Obstet Gynaecol 99 (1992) 731-734
13. Nilsson M., Johnsen R., Ye W., et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 290 (2003) 66-72
14. Mohammed I., Cherkas L.F., Riley S.A., et al. Genetic influences in gastro-oesophageal reflux disease: a twin study. Gut 52 (2003) 1085-1089
15. Jacobson B.C., Somers S.C., Fuchs C.S., et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 354 (2006) 2340-2348
16. Hampel H., Abraham N.S., and El-Serag H.B. Meta-analysis: obesity and the risk for gastroesophageal reflux disease and its complications. Ann Intern Med 143 (2005) 199-211
17. Zheng Z., Nordenstedt H., Pedersen N.L., et al. Lifestyle factors and risk for symptomatic gastroesophageal reflux in monozygotic twins. Gastroenterology 132 (2007) 87-95
18. El-Serag H.B., Ergun G.A., Pandolfino J., et al. Obesity increases oesophageal acid exposure. Gut 56 (2007) 749-755
19. Margolis K.L., Bonds D.E., Rodabough R.J., et al. Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial. Diabetologia 47 (2004) 1175-1187
20. Chen Z., Bassford T., Green S.B., et al. Postmenopausal hormone therapy and body composition-a substudy of the estrogen plus progestin trial of the Women's Health Initiative. Am J Clin Nutr 82 (2005) 651-656
21. Hsia J., Langer R.D., Manson J.E., et al. Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative. Arch Intern Med 166 (2006) 357-365
22. Stefanick M.L., Cochrane B.B., Hsia J., et al. The Women's Health Initiative postmenopausal hormone trials: overview and baseline characteristics of participants. Ann Epidemiol 13 Suppl (2003) S78-S86
23. Rossouw J.E., Anderson G.L., Prentice R.L., et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 288 (2002) 321-333
24. Anderson G.L., Limacher M., Assaf A.R., et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 291 (2004) 1701-1712
25. Locke III G.R., Talley N.J., Fett S.L., et al. Risk factors associated with symptoms of gastroesophageal reflux. Am J Med 106 (1999) 642-649
26. Pandolfino J.E., El-Serag H.B., Zhang Q., et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 130 (2006) 639-649
27. Corley D.A., Kubo A., Levin T.R., et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 133 (2007) 34-41 quiz 311
28. Moayyedi P., and Talley N.J. Gastro-oesophageal reflux disease. Lancet 367 (2006) 2086-2100
29. Nordenstedt H., Zheng Z., Cameron A.J., et al. Postmenopausal hormone therapy as a risk factor for gastroesophageal reflux symptoms among female twins. Gastroenterology 134 (2008) 921-928
30. Locke G.R., Talley N.J., Weaver A.L., et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 69 (1994) 539-547
31. Revicki D.A., Wood M., Wiklund I., et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 7 (1998) 75-83
32. Vakil N., van Zanten S.V., Kahrilas P., et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 101 (2006) 1900-1920 quiz 1943